Study Stopped
Integrated into another study
Simplified Medical Abortion Follow-Up
1 other identifier
interventional
53
1 country
1
Brief Summary
The purpose of this operations research study is to evaluate women's interest in and compliance with using a semiquantitative multi-level dipstick pregnancy test at home for medical abortion follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2015
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2015
CompletedFirst Submitted
Initial submission to the registry
August 11, 2015
CompletedFirst Posted
Study publicly available on registry
August 17, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2015
CompletedMarch 4, 2016
March 1, 2016
7 months
August 11, 2015
March 3, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patients' compliance in performing the semiquantitative pregnancy test and reporting results
This will be assessed with a survey administered at the scheduled follow-up phone call. The survey will determine if the patient performed the SQPT as requested, and whether they can interpret and report the results correctly.
Within 2 weeks after medical abortion
Study Arms (1)
Home-based follow-up with SQPT
EXPERIMENTALFor the intervention, a semiquantitative pregnancy test (SQPT) will be performed at the health center before the participants take mifepristone, and again two weeks later by the participants, at home. Study staff will call the participants at two weeks to follow-up with the participants.
Interventions
Participants will be followed-up at home. They will receive an SQPT to perform at home two weeks after enrollment, and a scheduled follow-up phone call by study providers to determine the outcome of the procedure.
Eligibility Criteria
You may qualify if:
- She has been determined by the site investigator or designee to be fully eligible for medical abortion with mifepristone followed by misoprostol according to the site's standard criteria;
- She is willing to use the semiquantitative pregnancy test at home;
- She is wiling and able to comply with the study procedures;
- She speaks and reads English;
- She has signed the study informed consent form.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Carafem Health Center
Chevy Chase, Maryland, 20815, United States
Study Officials
- STUDY DIRECTOR
Elizabeth Raymond, MD,MPH
Gynuity Health Projects
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 11, 2015
First Posted
August 17, 2015
Study Start
April 1, 2015
Primary Completion
November 1, 2015
Study Completion
November 1, 2015
Last Updated
March 4, 2016
Record last verified: 2016-03